Advertisement

Topics

Merrill Lynch & Co., Inc. Company Profile

07:51 EST 13th December 2018 | BioPortfolio

Merrill Lynch is one of the world's leading wealth management, capital markets and advisory companies, with offices in 36 countries and territories and total client assets of approximately $1.8 trillion, at the end of second quarter 2006.

Merrill Lynch has three core businesses – Global Private Client, Global Markets & Investment Banking Group and Merrill Lynch Investment Managers – offering a range of services for private clients, small businesses, institutions and corporations, and financial intermediariesMerrill Lynch & Co., Inc., is a Delaware corporation that, through its subsidiaries and affiliates, provides capital markets services, investment banking and advisory services, wealth management, asset management, insurance, banking and related products and services on a global basis, including:N107Securities brokerage and trading-quities
- Fixed income- Mutual fundsInvestment banking- Securities underwriting- Strategic advisory services, - Mergers and acquisitions - Strategic valuation - Other corporate finance and advisory activities

Location

4 World Financial Center250 Vesey Street
New York
New York
10080
United States of America

Contact

Phone: 1-212-449-1000


News Articles [99 Associated News Articles listed on BioPortfolio]

Merrill Lynch hebt Sanofi auf 'Buy'

Die US-Investmentbank Merrill Lynch hat Sanofi von "Neutral" auf "Buy" hochgestuft und das Kursziel von 80 auf 95 Euro erhöht. 2019 dürften die Franzosen auf den Wachstumsweg zurückkehren, schrieb....

Merrill Lynch senkt Roche auf 'Neutral'

Die US-Investmentbank Merrill Lynch hat Roche von "Buy" auf "Neutral" abgestuft und das Kursziel von 275 auf 265 Schweizer Franken gesenkt. Analyst Sachin Jain bevorzugt in der Pharmabranche aus d...

Merrill Lynch hebt Novartis auf 'Buy' - Ziel 100 Franken

Die US-Investmentbank Merrill Lynch hat Novartis von "Underperform" auf "Buy" hochgestuft und das Kursziel von 85 auf 100 Franken angehoben. Im kommenden Jahr werde es voraussichtlich keine Generi...

ANALYSE-FLASH: Merrill Lynch senkt Roche auf 'Neutral'

Die US-Investmentbank Merrill Lynch hat Roche von "Buy" auf "Neutral" abgestuft und das Kursziel von 275 auf 265 Schweizer Franken gesenkt. Analyst Sachin Jain bevorzugt in der Pharmabranche aus d...

Merrill Lynch senkt Ziel für Bayer auf 105 Euro - 'Buy'

Die US-Investmentbank Merrill Lynch hat das Kursziel für Bayer nach Zahlen zum dritten Quartal von 115 auf 105 Euro gesenkt und die Einstufung auf "Buy" belassen. Einmal mehr senke er seine Schätz.....

Endo to Participate at Bank of America Merrill Lynch Leveraged Finance Conference

DUBLIN, Nov. 28, 2018 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that members of management will participate in a fireside chat at the Bank of America Merrill Lynch Leve...

Intel-Aktie wird von Unsicherheit überschattet!

Charlotte (www.aktiencheck.de) - Intel-Aktienanalyse des Analysten Vivek Arya von BofA Merrill Lynch Research: Vivek Arya, Aktienanalyst von BofA Merrill Lynch Research, bekräftigt laut einer Aktie.....

Sarepta Therapeutics: Coverage wird wieder aufgenommen!

Charlotte (www.aktiencheck.de) - Sarepta Therapeutics-Aktienanalyse des Analysten Tazeen Ahmad von BofA Merrill Lynch Research: Analyst Tazeen Ahmad vom Investmenthaus BofA Merrill Lynch Research s...

Drugs and Medications [2 Associated Drugs and Medications listed on BioPortfolio]

Trazodone [PD-Rx Pharmaceuticals, Inc.]

TRAZODONE HYDROCHLORIDE TABLETS, USP

Trazodone [PD-Rx Pharmaceuticals, Inc.]

TRAZODONE HYDROCHLORIDE TABLETS, USP

PubMed Articles [40 Associated PubMed Articles listed on BioPortfolio]

DNA mismatch repair protein deficient non-neoplastic colonic crypts: a novel indicator of Lynch syndrome.

Lynch syndrome is the most common form of hereditary colorectal carcinoma. However, establishing the diagnosis of Lynch syndrome is challenging, and ancillary studies that distinguish between sporadic...

Routine molecular analysis for Lynch syndrome among adenomas or colorectal cancer within a national screening program.

It is important to identify individuals with Lynch syndrome because surveillance programs can reduce their morbidity and mortality from colorectal cancer (CRC). We assessed the diagnostic yield of imm...

Worldwide Practice Patterns in Lynch Syndrome Diagnosis and Management, Based on Data From the International Mismatch Repair Consortium.

Families with a history of Lynch syndrome often do not adhere to guidelines for genetic testing and screening. We investigated practice patterns related to Lynch syndrome worldwide, to ascertain poten...

Molecular subtype classification of urothelial carcinoma in Lynch syndrome.

Lynch syndrome confers an increased risk for urothelial carcinoma (UC). Molecular subtypes may be relevant to prognosis and therapeutic possibilities, but have to date not been defined in Lynch syndro...

Medical Devices; Hematology and Pathology Devices; Classification of Lynch Syndrome Test Systems. Final order.

The Food and Drug Administration (FDA or we) is classifying Lynch syndrome test systems into class II (special controls). The special controls that apply to the device type are identified in this or...

Clinical Trials [33 Associated Clinical Trials listed on BioPortfolio]

Diagnosis of Lynch Syndrome Based on Next-generation Sequencing in Patients Meeting Chinese Lynch Syndrome Criteria

The purpose of this study is to find out the proportion of patients diagnosed with Lynch syndrome in colorectal cacner patients meeting Chinese Lynch syndrome criteria. Besides, this study...

Universal Screening for Lynch Syndrome in Women With Endometrial and Non-Serous Ovarian Cancer

This study will maximize identification of women with Lynch Syndrome using an enhanced screening strategy to identify those at risk. These women will be referred to genetic counselling fo...

Linked Color Imaging Versus High-definition White Light Endoscopy for the Detection of Polyps in Patients With Lynch Syndrome (LCI-LYNCH)

The aim of the present study is to compare polyp detection rates of LCI with high-definition white light endoscopy (HD-WLE) in patients with Lynch syndrome in a parallel, international, mu...

CYCling Lynch Patients for Exercise and Prevention: CYCLE-P

The goal of this research study is to learn if sustained exercise can affect the outcomes in patients with a specific type of colorectal cancer called Lynch Syndrome . This is an investig...

High Definition White-Light Colonoscopy vs. Chromoendoscopy for Surveillance of Lynch Syndrome.

Adenomas in Lynch syndrome have an accelerated progression to colorectal cancer (CRC) which might occur despite a regular follow-up. Despite low evidence, high-definition technology (HD) a...

Companies [16 Associated Companies listed on BioPortfolio]

Merrill Lynch & Co., Inc.

Merrill Lynch is one of the world's leading wealth management, capital markets and advisory companies, with offices in 36 countries and territories and total client assets of approximately $1.8 trilli...

Bank of America Merrill Lynch

Merrill Corporation

Founded in 1968 and headquartered in St. Paul, Minn., Merrill Corporation (http://www.merrillcorp.com) is a leading provider of outsourced solutions for complex business communication and informat...

Centerview Partners

Alan Hartman joins Centerview Partners from Merrill Lynch where he has been in the mergers and acquisitions group for the past 15 years, most recently as Head of Americas M&A and Global Head of He...

Xiotech

Xiotech helps you accomplish your goals. This dedication to customers has led to Xiotech's tremendous growth and success. In 2004 Xiotech achieved record 25% revenue growth. Merrill Lynch, Bechtel, Lu...

More Information about "Merrill Lynch & Co., Inc." on BioPortfolio

We have published hundreds of Merrill Lynch & Co., Inc. news stories on BioPortfolio along with dozens of Merrill Lynch & Co., Inc. Clinical Trials and PubMed Articles about Merrill Lynch & Co., Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Merrill Lynch & Co., Inc. Companies in our database. You can also find out about relevant Merrill Lynch & Co., Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record